- This course aims to provide advanced knowledge and skills for health care professionals on the topic of biosimilars, a class of biologic drugs or medical therapies that are highly similar to an existing originator medication that is off patent.
- Biosimilars present a rapidly growing area in pharmaceutical development, treatment options, and patient care that require an evidence-informed implementation approach.
- This course aims to provide advanced knowledge and skills for health care professionals on the topic of biosimilars, a class of biologic drugs or medical therapies that are highly similar to an existing originator medication that is off patent.
- Biosimilars present a rapidly growing area in pharmaceutical development, treatment options, and patient care that require an evidence-informed implementation approach.
- As awareness and use of biosimilars increases globally, this course will provide information and guidance to support the effective and safe use of biosimilars in clinical settings among health care providers.
- The course will focus on enhancing knowledge and skills to affect change in attitude and behaviour of health care providers related to biosimilars.
- The course will utilize a modular approach to provide content that is accessible and informative to all learners, including pharmacists, physicians, nurses, students and young professionals, industry, and policy-makers.
- This course may be eligible for continuing education credits through professional accreditation bodies.
- The course will also provide learners with opportunities to develop skills in each of these knowledge areas, with the overall aim of improving patient-provider communication and perceptions of biosimilar use and establishing a consistent foundation among health care providers for communicating with patients about biosimilar treatment.
- This course will build off of the material in BSS101 to provide advanced knowledge and skills related to use and implementation of biosimilar medications in clinical settings.
Improve knowledge of originator biologic and biosimilar biologic medicines
Understand scientific and clinical evidence to support appropriate cost-effective application of biosimilars across oncology, rheumatology, gastrointestinal disease, and other medical conditions
Address misconceptions regarding use of biosimilars
Identify the benefits and significance of biosimilar use in clinical practice and across jurisdictions
Discuss implications of biosimilar use for clinical practice and patient education to optimize patient care and wellness
OpenCourser helps millions of learners each year. People visit us to learn workspace skills, ace their exams, and nurture their curiosity.
Our extensive catalog contains over 50,000 courses and twice as many books. Browse by search, by topic, or even by career interests. We'll match you to the right resources quickly.
Find this site helpful? Tell a friend about us.
We're supported by our community of learners. When you purchase or subscribe to courses and programs or purchase books, we may earn a commission from our partners.
Your purchases help us maintain our catalog and keep our servers humming without ads.
Thank you for supporting OpenCourser.